MCN-03-Jun-2020 Related News
From plant to patients: pharmaceutical grade cannabis solutions
Combining the best of science and agritech to pave the path for pharmaceutical grade cannabis solutions.
Natural products have been the backbone of traditional healing...
Expanding the boundaries of medical cannabis clinical evidence
Expanding the boundaries of medical cannabis clinical evidence; removing barriers to medical cannabis practice.
In this article, Amit Sade, of Sade Group, discusses expanding medical...
Shipping medical cannabis: a Dutch perspective
Malti Ramdharie of CIBG tells MCN about the shipping and supply of medical cannabis in the Netherlands.
Dutch patients have been able to access medical...
How have Cannabis 2.0 and COVID-19 affected the industry?
Cannabis Council of Canada President and CEO George Smitherman tells MCN about the Cannabis 2.0 rollout, COVID-19, and the future of Canadian cannabis policy.
In...
Creating market-leading cannabis-infused products for Europe
Premium cannabis-infused products built on cutting edge extraction, purification and emulsion technologies will win against generic, undifferentiated products.
Europe has seen significant investment and advancement...
Policy, accessibility, and human rights in Malta
Andrew Bonello, President of Releaf Malta, speaks to MCN about policy, accessibility, human rights, and medical cannabis in Malta and the issues patients still...
Cannaponics: cultivation and revitalisation in Western Australia
“This movement is more than just a phenomenon, it is a necessity. At Cannaponics Limited we are committed to leading a movement, not just...
Hemp Futures: a growing hemp producer in Estonia
Stephen J Wyatt, founder and CEO of Hemp Futures, based in Estonia, tells MCN about the importance of customer engagement and accountability.
Estonia-based CBD producer...
The bright future of the CBD market and the impact of COVID-19
SovereignPort CEO Sarah Roberts Yetman speaks to MCN about the future of the global CBD market and fears over the long term impact of COVID-19.
Sarah...
Medical cannabis policy and practice in Germany
Dr Franjo Grotenhermen tells MCN about medical cannabis policy and practice in Germany.
Doctor, author and cannabis advocate Dr Franjo Grotenhermen is founder and Executive...
Medical cannabis treatment in the UK with Professor Mike Barnes
Medical cannabis expert Professor Mike Barnes discusses Medical cannabis treatment and highlights the challenges facing cannabis in the UK.
Consultant neurologist and medical cannabis treatment...
Quality control and analysis in medical cannabis production
MCN speaks to independent consulting firm NNE about how quality control, testing, and analysis in medical cannabis production can benefit patients.
Independent consultancy NNE operates...
Engineering environmental controls for efficient indoor cultivation
Grow2Guys offers lessons from North America for European indoor cultivation facilities.
Grow2Guys, a division of urban-gro, Inc, has provided full-service mechanical, electrical, and plumbing (MEP)...
Sanity Group: unlocking the health benefits of cannabinoid medicines
Sanity Group puts people first to improve patient access and drive innovation, and utilises the health benefits of cannabinoid medicines.
Putting people first, as well...
The CryoEXS Advantage: industrial extraction technology for cannabis
Explore the benefits of investing in the latest industrial scale extraction technology for cannabis processing facilities - CryoEXS extraction systems.
Root Sciences established one of...
Education, development, and campaigning for patient access to medical cannabis
Althea’s mission is to alleviate the suffering of patients with debilitating conditions through education, development, and campaigning for patient access to medical cannabis.
The primary...
Cloud 9: high quality standards for hemp and cannabis products
Cloud 9 Group leverages its strong principles and high quality standards to produce premium hemp and cannabis products.
The Cloud 9 Group of private companies...
Exploring growth in the European medical cannabis market
Luc Springinsfeld of leading investment bank Bryan, Garnier & Co explores the European medical cannabis market and the rise of medical cannabis investment in...
Khiron Life Sciences: expanding into Europe with patient focus
Global cannabis leader Khiron Life Sciences is expanding into the European sector with a patient focus.
Khiron Life Sciences is a vertically integrated global cannabis...
The wellness revolution with Medicaleaf
A coronavirus ‘good news’ story from innovator Medicaleaf, looking at the wellness revolution.
When a group of relative strangers with myriad strengths, experience and expertise...
